Published in Mol Pain on February 12, 2015
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. Oncotarget (2016) 0.87
Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res Ther (2016) 0.80
Inhibition of neuropathic hyperalgesia by intrathecal bone marrow stromal cells is associated with alteration of multiple soluble factors in cerebrospinal fluid. Exp Brain Res (2017) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain (1992) 9.17
Molecular mechanisms of nociception. Nature (2001) 7.75
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell (2009) 7.62
The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs (2001) 4.31
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood (2005) 2.39
Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol (2012) 2.36
Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res (2010) 2.09
Potent analgesic effects of GDNF in neuropathic pain states. Science (2000) 2.06
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther (2005) 1.91
Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol (2014) 1.90
Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood (2011) 1.76
Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells (2006) 1.74
Detection of neuropathic pain in a rat model of peripheral nerve injury. Anesthesiology (2004) 1.66
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res (2011) 1.62
Transplantation of engineered heart tissue as a biological cardiac assist device for treatment of dilated cardiomyopathy. Eur J Heart Fail (2013) 1.54
Selective nerve root blocks for the treatment of sciatica: evaluation of injection site and effectiveness--a study with patients and cadavers. Radiology (2001) 1.45
Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol Cell Biol (2012) 1.43
Differential role of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG neurons. Brain Res Mol Brain Res (1999) 1.40
Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation (2013) 1.39
Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Ther (2007) 1.37
Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res (2010) 1.35
Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med (2012) 1.32
Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol (2008) 1.32
The life and fate of mesenchymal stem cells. Front Immunol (2014) 1.27
Design and construction of 2A peptide-linked multicistronic vectors. Cold Spring Harb Protoc (2012) 1.26
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev (2010) 1.25
Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer (2010) 1.17
Virus activated artificial ECM induces the osteoblastic differentiation of mesenchymal stem cells without osteogenic supplements. Sci Rep (2013) 1.17
IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant (2007) 1.15
Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis (2008) 1.15
Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J (2009) 1.13
Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells (2014) 1.12
Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther (2011) 1.12
Learned avoidance from noxious mechanical simulation but not threshold semmes weinstein filament stimulation after nerve injury in rats. J Pain (2009) 1.10
Spinal nerve ligation: what to blame for the pain and why. Pain (2000) 1.08
Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol Life Sci (2009) 1.07
HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Mol Ther (2003) 1.07
Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia. Stem Cell Res Ther (2011) 1.06
Lentiviral vector integration profiles differ in rodent postmitotic tissues. Mol Ther (2011) 1.06
Importance of hyperexcitability of DRG neurons in neuropathic pain. Pain Pract (2002) 1.06
Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther (2014) 1.05
Lentiviral gene transfer into the dorsal root ganglion of adult rats. Mol Pain (2011) 1.03
Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. Cell Transplant (2005) 1.02
Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci (2011) 1.00
Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Stem Cells (2011) 0.99
Direct injection into the dorsal root ganglion: technical, behavioral, and histological observations. J Neurosci Methods (2011) 0.98
Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. Stem Cell Rev (2014) 0.98
Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat. J Virol (2010) 0.95
DAPI diffusion after intravitreal injection of mesenchymal stem cells in the injured retina of rats. Cell Transplant (2009) 0.91
Influence of intrathecal delivery of bone marrow-derived mesenchymal stem cells on spinal inflammation and pain hypersensitivity in a rat model of peripheral nerve injury. J Neuroinflammation (2014) 0.90
Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells. J Cell Sci (2013) 0.89
Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease. J Neurosci Res (2010) 0.89
Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing. BMC Biotechnol (2012) 0.89
Overexpression of GDNF in the uninjured DRG exerts analgesic effects on neuropathic pain following segmental spinal nerve ligation in mice. J Pain (2011) 0.86
Selective migration and engraftment of bone marrow mesenchymal stem cells in rat lumbar dorsal root ganglia after sciatic nerve constriction. Neurosci Lett (2006) 0.85
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases. Int J Mol Sci (2014) 0.84
Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. J Neurochem (2008) 0.84
Intrathecal transplantation of neural stem cells appears to alleviate neuropathic pain in rats through release of GDNF. Ann Clin Lab Sci (2013) 0.83
Assessment of the green florescence protein labeling method for tracking implanted mesenchymal stem cells. Cytotechnology (2012) 0.82
Concise review: stem cell therapies for neuropathic pain. Stem Cells Transl Med (2013) 0.81
Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain. Mol Pain (2009) 0.81
Transplantation of human mesenchymal stem cells in the study of neuropathic pain. Methods Mol Biol (2010) 0.80
Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells. J Tissue Eng (2014) 0.80
In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow. PLoS One (2012) 0.78
Augmenting glial cell-line derived neurotrophic factor signaling to treat painful neuropathies. Proc Natl Acad Sci U S A (2014) 0.78
Mesenchymal stem cells develop tumor tropism but do not accelerate breast cancer tumorigenesis in a somatic mouse breast cancer model. PLoS One (2013) 0.77
Cell transplantation as a pain therapy targets both analgesia and neural repair. Cell Transplant (2013) 0.77
Cellular therapies for treating pain associated with spinal cord injury. J Transl Med (2012) 0.76